Gothenburg – Vitrolife is a global biotechnology/medical device Group that works with developing, manufacturing and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue and organs. The company has business activities within three product areas: Fertility, Transplantation and Stem Cell Cultivation. The Fertility product area works with nutrient solutions […]

GOETTINGEN, Germany – Sartorius, a leading international laboratory and process equipment provider, successfully closed the first nine months of 2011, with double-digit growth rates in sales revenue and earnings. Group CEO Dr. Joachim Kreuzburg, satisfied with good business development shown by the company’s quarterly figures released, stated, “Both divisions and all regions have delivered growth […]

WALTHAM, Mass.–PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has priced an offering of $500,000,000 aggregate principal amount of 5.00% senior notes due 2021 at an issue price of 99.372% of the principal amount. The issuance of the notes is expected to […]

VICTORIA, British Columbia–GenoLogics, a leading provider of laboratory information management system (LIMS) software specifically designed for next-generation genomics labs, today announced an $8 million round of strategic financing led by new investor Illumina, Inc., a global leader in next-generation sequencing (NGS) instruments. The financing will be used to accelerate product development for future clinical applications […]

SUNNYVALE, Calif. — Cepheid today reported revenues for the third quarter of 2011 of $70.2 million. Net income was $1.9 million, or $0.03 per share, which compares to revenues of $56.1 million and a net loss of $1.1 million, or $(0.02) per share, in the third quarter of 2010. Excluding amortization of purchased intangible assets […]

WHITE PLAINS, N.Y. — ITT Corporation today announced the final results and definitive prices for its previously announced modified “Dutch Auction” cash tender offer (the “Offer”) for up to $100 million aggregate principal amount (the “Tender Cap”) of its 7.40% Debentures due 2025 (the “Debentures”). The Offer was conducted in connection with ITT’s plan to […]

SOUTH EASTON, Mass. — Pressure BioSciences, Inc. today announced that all remaining holders of its Series A and B Convertible Preferred Stock have voluntarily converted their shares into Common Stock of the Company. As a result of these conversions, one-hundred percent (100%) of the Company’s 345,314 shares of Series A and B Convertible Preferred Stock […]

FREDERICK, Md.–Akonni Biosystems, a molecular diagnostics company focused on commercializing rapid sample preparation and molecular diagnostics systems for the detection of infectious diseases, and CUBRC, Inc., have been awarded a $774,000 contract by the U.S. Army to develop an automated sample preparation system for isolating biological threat indicators for downstream use with field-based detection systems. […]

SOUTH EASTON, Mass. — Pressure BioSciences, Inc. today announced that it has been awarded a $649,498 SBIR Phase II grant (W81XWH-10-C-0175) from the U.S. Department of Defense (“DoD”). Entitled “Development of a Universal Method for Diagnostic Sample Inactivation, Extraction, and Enrichment of Pathogens in Arthropod Hosts of Military Importance”, this grant will help fund the […]

MOUNTAIN VIEW, Calif. — DNAnexus, a DNA data management and analysis platform, today announced that it has secured $15 million in second-round funding, led by Google Ventures and TPG Biotech. Additional participants in this round of financing include institutional investors First Round Capital, SoftTech VC, K9 Ventures, and Felicis Ventures. The new capital will help […]